Bausch + Lomb line extends PreserVision with new chewable
Bausch + Lomb recently launched PreserVision AREDS 2 Formula Chewable vitamins, designed to meet the growing consumer preference for chewable tablets in a mixed berry flavor.
“We are dedicated to providing consumers with products that can address a wide range of their eye health needs,” Joseph Gordon, president, Consumer Healthcare and Vision Care, Bausch + Lomb, said. “With the addition of PreserVision AREDS 2 Formula Chewable vitamins to our portfolio, we are able to help more people by offering a convenient new way to make PreserVision part of their eye care routine.”
Approximately 20% of adults age 50 and older report experiencing some degree of swallowing difficulty, which can impact their ability to take vitamins and supplements important to supporting their health. Among those with difficulty swallowing, 78% and 65% of consumers surveyed rank ease of administration and not needing water, respectively, as important attributes of chewable pills and contributing factors for increased compliance.
“Taking a nutritional supplement such as PreserVision AREDS 2 Formula vitamins, as part of a care plan recommended to patients by their doctors, that includes a healthy diet and exercise, helps to reduce the risk of progression of moderate and advanced AMD, a leading cause of vision loss in Americans age 50 and older,” Michael Cooney, a consultant with the Vitreous Retina Macula Consultants of New York, said. “I am pleased to recommend this convenient new option to my patients; a growing number of whom report difficulty swallowing and have often inquired about the availability of a chewable form of the AREDS 2 Formula vitamins.”
PreserVision AREDS 2 Formula Chewable vitamins will be available for purchase in the vitamin aisle at major retailers by June 2018.
PreserVision AREDS 2 Formula vitamins are the only vitamins that contain the exact levels of six key nutrients recommended by the National Eye Institute, Bausch + Lomb reported. Bausch + Lomb operates out of Bridgewater, N.J.
“We are dedicated to providing consumers with products that can address a wide range of their eye health needs,” Joseph Gordon, president, Consumer Healthcare and Vision Care, Bausch + Lomb, said. “With the addition of PreserVision AREDS 2 Formula Chewable vitamins to our portfolio, we are able to help more people by offering a convenient new way to make PreserVision part of their eye care routine.”
Approximately 20% of adults age 50 and older report experiencing some degree of swallowing difficulty, which can impact their ability to take vitamins and supplements important to supporting their health. Among those with difficulty swallowing, 78% and 65% of consumers surveyed rank ease of administration and not needing water, respectively, as important attributes of chewable pills and contributing factors for increased compliance.
“Taking a nutritional supplement such as PreserVision AREDS 2 Formula vitamins, as part of a care plan recommended to patients by their doctors, that includes a healthy diet and exercise, helps to reduce the risk of progression of moderate and advanced AMD, a leading cause of vision loss in Americans age 50 and older,” Michael Cooney, a consultant with the Vitreous Retina Macula Consultants of New York, said. “I am pleased to recommend this convenient new option to my patients; a growing number of whom report difficulty swallowing and have often inquired about the availability of a chewable form of the AREDS 2 Formula vitamins.”
PreserVision AREDS 2 Formula Chewable vitamins will be available for purchase in the vitamin aisle at major retailers by June 2018.
PreserVision AREDS 2 Formula vitamins are the only vitamins that contain the exact levels of six key nutrients recommended by the National Eye Institute, Bausch + Lomb reported. Bausch + Lomb operates out of Bridgewater, N.J.